Invitae Corporation (NVTA): Price and Financial Metrics
Invitae Corporation (NVTA)
Today's Latest Price: $19.55 USD
0.68 (-3.36%)
Updated Feb 28 1:11pm
Add NVTA to WatchlistSign Up
POWR Components:
Trade Grade Buy & Hold Grade Peer Grade Industry Rank
Industry Rank:
Ranked of 58 in Medical - Diagnostics/Research
See all "A" rated Strong Buy stocks
NVTA Stock Summary
- NVTA's price/sales ratio is 9.65; that's higher than the P/S ratio of 87.65% of US stocks.
- With a year-over-year growth in debt of 408.43%, Invitae Corp's debt growth rate surpasses 95% of about US stocks.
- Revenue growth over the past 12 months for Invitae Corp comes in at 53.35%, a number that bests 90.18% of the US stocks we're tracking.
- If you're looking for stocks that are quantitatively similar to Invitae Corp, a group of peers worth examining would be ADMP, GNMK, TTOO, OOMA, and ARLO.
- Visit NVTA's SEC page to see the company's official filings. To visit the company's web site, go to www.invitae.com.
NVTA Daily Price Range
NVTA 52-Week Price Range
NVTA Stock Price Chart More Charts
NVTA Price/Volume Stats
| Current price | $19.55 | 52-week high | $28.75 |
| Prev. close | $20.23 | 52-week low | $14.35 |
| Day low | $18.83 | Volume | 1,794,561 |
| Day high | $20.25 | Avg. volume | 3,368,045 |
| 50-day MA | $19.61 | Dividend yield | N/A |
| 200-day MA | $20.36 | Market Cap | 1.89B |
Invitae Corporation (NVTA) Company Bio
Invitae Corporation is a company that utilizes an integrated portfolio of laboratory processes, software tools and informatics capabilities to process deoxyribonucleic acid (DNA)-containing samples, analyze information about patient-specific genetic variation and generate test reports for physicians and their patients. The company was founded in 2012 and is based in San Francisco, California.
Top Stories View All
The Correct Mindset to Have After the Stock Market Plummets
Cannabis Stocks: The Week in Review
Best & Worst Performing Stock Industries for February 27, 2020
Best & Worst Performing Small Cap Stocks for February 27, 2020
Best & Worst Performing Mid Cap Stocks for February 27, 2020
View All Top Stories
Loading social stream, please wait...